Join us for a live webinar designed to support oncology clinicians in navigating the evolving treatment landscape of extensive-stage small cell lung cancer (ES-SCLC). As novel therapies, including antibody-drug conjugates, bispecific T-cell engagers, and immunotherapy combinations, move through clinical trials, community oncology teams are facing growing challenges in integrating these advances into practice. This expert-led session will present the latest clinical evidence through a focused agenda designed to address educational gaps identified in a recent nationwide survey of oncology providers. Topics will include real-world treatment challenges, current standards of care, and the integration of novel therapies into practice. Faculty will also explore emerging biomarkers, evolving mechanisms of action, and practical strategies to improve clinical trial access for patients with ES-SCLC. Attendees will gain access to a downloadable Clinical Trial Pocket Guide to support clinical decision-making and trial referrals beyond the program. The webinar will conclude with an interactive case discussion and a live "Ask the Expert" Q&A session where you can engage directly with faculty and refine your approach to individualized care.